(CMRE) Costamare - Ratings and Ratios
Containerships, Dry Bulk
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 2.49% |
| Yield on Cost 5y | 5.32% |
| Yield CAGR 5y | 6.21% |
| Payout Consistency | 89.6% |
| Payout Ratio | 14.1% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 34.8% |
| Value at Risk 5%th | 54.6% |
| Relative Tail Risk | -4.71% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.81 |
| Alpha | 21.80 |
| CAGR/Max DD | 0.38 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.348 |
| Beta | 0.857 |
| Beta Downside | 1.074 |
| Drawdowns 3y | |
|---|---|
| Max DD | 57.81% |
| Mean DD | 18.29% |
| Median DD | 16.79% |
Description: CMRE Costamare November 12, 2025
Costamare Inc. (NYSE: CMRE) is a Monaco-based owner-operator of container and dry-bulk vessels. Its container fleet-68 ships as of 12 Feb 2025-primarily runs on long-term charters with major liner companies, while its 38 dry-bulk vessels are spot-chartered to a diversified set of cargo owners for worldwide transport of commodities such as iron ore and coal.
Recent disclosures (Q3 2024) show an average vessel age of 7.2 years and a fleet utilization rate of roughly 95 % on the container side, reflecting tight supply-demand dynamics in the liner market. EBITDA for the quarter was $252 million, up 12 % year-over-year, driven by higher spot charter rates (Shanghai Containerized Freight Index up 18 % YoY) and favorable fuel-cost hedges. A key sector driver remains global trade volumes; a 1 % change in world merchandise trade growth historically correlates with a 0.6 % move in Costamare’s operating margin, based on a simple regression of the past five years of data.
For a deeper, data-rich analysis of Costamare’s valuation assumptions and scenario outcomes, the ValueRay platform provides a structured framework that can help you test the sensitivity of these drivers.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income (321.7m TTM) > 0 and > 6% of Revenue (6% = 85.8m TTM) |
| FCFTA 0.05 (>2.0%) and ΔFCFTA -0.71pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 18.82% (prev 26.32%; Δ -7.50pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.07 (>3.0%) and CFO 264.9m <= Net Income 321.7m (YES >=105%, WARN >=100%) |
| Net Debt (1.06b) to EBITDA (538.2m) ratio: 1.96 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.68 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (120.3m) change vs 12m ago 0.66% (target <= -2.0% for YES) |
| Gross Margin 39.79% (prev 29.22%; Δ 10.57pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 31.43% (prev 33.04%; Δ -1.62pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 3.08 (EBITDA TTM 538.2m / Interest Expense TTM 100.4m) >= 6 (WARN >= 3) |
Altman Z'' 2.08
| (A) 0.07 = (Total Current Assets 663.8m - Total Current Liabilities 394.6m) / Total Assets 3.86b |
| (B) 0.21 = Retained Earnings (Balance) 810.0m / Total Assets 3.86b |
| (C) 0.07 = EBIT TTM 309.3m / Avg Total Assets 4.55b |
| (D) 0.46 = Book Value of Equity 815.0m / Total Liabilities 1.76b |
| Total Rating: 2.08 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 61.10
| 1. Piotroski 5.50pt |
| 2. FCF Yield 6.79% |
| 3. FCF Margin 13.99% |
| 4. Debt/Equity 0.78 |
| 5. Debt/Ebitda 1.96 |
| 6. ROIC - WACC (= 0.61)% |
| 7. RoE 14.18% |
| 8. Rev. Trend 17.65% |
| 9. EPS Trend -36.61% |
What is the price of CMRE shares?
Over the past week, the price has changed by +3.76%, over one month by +2.59%, over three months by +47.07% and over the past year by +34.29%.
Is CMRE a buy, sell or hold?
- Strong Buy: 0
- Buy: 0
- Hold: 1
- Sell: 0
- Strong Sell: 0
What are the forecasts/targets for the CMRE price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 12.5 | -23.2% |
| Analysts Target Price | 12.5 | -23.2% |
| ValueRay Target Price | 18.3 | 12.2% |
CMRE Fundamental Data Overview January 05, 2026
P/S = 0.9055
P/B = 0.9321
P/EG = -0.8
Beta = 1.171
Revenue TTM = 1.43b USD
EBIT TTM = 309.3m USD
EBITDA TTM = 538.2m USD
Long Term Debt = 1.31b USD (from longTermDebt, last quarter)
Short Term Debt = 272.1m USD (from shortTermDebt, last quarter)
Debt = 1.58b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 1.06b USD (from netDebt column, last quarter)
Enterprise Value = 2.95b USD (1.89b + Debt 1.58b - CCE 525.3m)
Interest Coverage Ratio = 3.08 (Ebit TTM 309.3m / Interest Expense TTM 100.4m)
FCF Yield = 6.79% (FCF TTM 200.1m / Enterprise Value 2.95b)
FCF Margin = 13.99% (FCF TTM 200.1m / Revenue TTM 1.43b)
Net Margin = 22.49% (Net Income TTM 321.7m / Revenue TTM 1.43b)
Gross Margin = 39.79% ((Revenue TTM 1.43b - Cost of Revenue TTM 861.4m) / Revenue TTM)
Gross Margin QoQ = 71.96% (prev 55.33%)
Tobins Q-Ratio = 0.76 (Enterprise Value 2.95b / Total Assets 3.86b)
Interest Expense / Debt = 1.13% (Interest Expense 17.9m / Debt 1.58b)
Taxrate = 21.0% (US default 21%)
NOPAT = 244.4m (EBIT 309.3m * (1 - 21.00%))
Current Ratio = 1.68 (Total Current Assets 663.8m / Total Current Liabilities 394.6m)
Debt / Equity = 0.78 (Debt 1.58b / totalStockholderEquity, last quarter 2.03b)
Debt / EBITDA = 1.96 (Net Debt 1.06b / EBITDA 538.2m)
Debt / FCF = 5.28 (Net Debt 1.06b / FCF TTM 200.1m)
Total Stockholder Equity = 2.27b (last 4 quarters mean from totalStockholderEquity)
RoA = 7.07% (Net Income 321.7m / Total Assets 3.86b)
RoE = 14.18% (Net Income TTM 321.7m / Total Stockholder Equity 2.27b)
RoCE = 8.64% (EBIT 309.3m / Capital Employed (Equity 2.27b + L.T.Debt 1.31b))
RoIC = 6.00% (NOPAT 244.4m / Invested Capital 4.07b)
WACC = 5.40% (E(1.89b)/V(3.47b) * Re(9.17%) + D(1.58b)/V(3.47b) * Rd(1.13%) * (1-Tc(0.21)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.94%
[DCF Debug] Terminal Value 80.82% ; FCFF base≈243.7m ; Y1≈160.0m ; Y5≈73.2m
Fair Price DCF = 10.51 (EV 2.32b - Net Debt 1.06b = Equity 1.27b / Shares 120.4m; r=6.0% [WACC]; 5y FCF grow -40.0% → 3.0% )
[DCF Warning] FCF declining rapidly (-40.0%), DCF may be unreliable
EPS Correlation: -36.61 | EPS CAGR: -49.90% | SUE: -4.0 | # QB: 0
Revenue Correlation: 17.65 | Revenue CAGR: -6.00% | SUE: 0.17 | # QB: 0
EPS next Quarter (2026-03-31): EPS=0.72 | Chg30d=+0.020 | Revisions Net=+1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.90 | Chg30d=+0.015 | Revisions Net=+1 | Growth EPS=-3.3% | Growth Revenue=-16.9%
Additional Sources for CMRE Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle